These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11745872)

  • 21. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
    Malempati S; Weigel BJ; Chi YY; Tian J; Anderson JR; Parham DM; Teot LA; Rodeberg DA; Yock TI; Shulkin BL; Spunt SL; Meyer WH; Hawkins DS
    Cancer; 2019 Jan; 125(2):290-297. PubMed ID: 30351457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
    J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
    Felgenhauer J; Hawkins D; Pendergrass T; Lindsley K; Conrad EU; Miser JS
    Med Pediatr Oncol; 2000 Jan; 34(1):29-38. PubMed ID: 10611582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.
    Pappo AS; Lyden E; Breneman J; Wiener E; Teot L; Meza J; Crist W; Vietti T
    J Clin Oncol; 2001 Jan; 19(1):213-9. PubMed ID: 11134215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
    Ruymann FB; Grovas AC
    Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.
    Bergeron C; Thiesse P; Rey A; Orbach D; Boutard P; Thomas C; Schmitt C; Scopinaro MJ; Bernard F; Stevens M; Oberlin O
    Eur J Cancer; 2008 Feb; 44(3):427-31. PubMed ID: 18215514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
    Pappo AS; Etcubanas E; Santana VM; Rao BN; Kun LE; Fontanesi J; Roberson PK; Bowman LC; Crist WM; Shapiro DN
    Cancer; 1993 Mar; 71(6):2119-25. PubMed ID: 8443761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Intergroup Rhabdomyosarcoma Study-I. A final report.
    Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J
    Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
    Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
    Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
    Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
    Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997.
    Raney RB; Anderson JR; Andrassy RJ; Crist WM; Donaldson SS; Maurer HM;
    J Pediatr Hematol Oncol; 2000; 22(6):510-4. PubMed ID: 11132218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
    Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
    J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.
    Bisogno G; Ferrari A; Bergeron C; Scagnellato A; Prete A; Alaggio R; Casanova M; D'Angelo P; Di Cataldo A; Carli M
    Cancer; 2005 Apr; 103(8):1719-24. PubMed ID: 15754335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
    Noujaim J; Thway K; Jones RL; Miah A; Khabra K; Langer R; Kasper B; Judson I; Benson C; Kollàr A
    Anticancer Res; 2015 Nov; 35(11):6213-7. PubMed ID: 26504053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
    Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
    Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
    Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
    Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Gupta AA; Anderson JR; Pappo AS; Spunt SL; Dasgupta R; Indelicato DJ; Hawkins DS
    Cancer; 2012 Feb; 118(4):1130-7. PubMed ID: 21761400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.